Sign inGet started

GANNON STEVEN

Insider CIK 1643085 · XENE Director · FUSN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
XENE Xenon Pharmaceuticals Inc. S Sale2026-08-112026-08-1310,000$64.06 $640.6K1,870SEC↗
XENE Xenon Pharmaceuticals Inc. S Sale2026-08-112026-08-1310,000$64.06 $640.5K1,870SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2026-06-032026-06-0310,507— $010,507SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2026-06-032026-06-031,593— $01,593SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise deriv2026-06-012026-06-032,645— $00SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise2026-06-012026-06-032,645— $013,286SEC↗
XENE Xenon Pharmaceuticals Inc. F Tax w/h2026-06-012026-06-031,416$53.41 $75.6K11,870SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise deriv2026-05-122026-05-133,500— $00SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise2026-05-122026-05-133,500$7.38 $25.8K10,641SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2025-06-052025-06-062,645— $02,645SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2025-06-052025-06-0617,012— $017,012SEC↗
XENE Xenon Pharmaceuticals Inc. S Sale2025-06-052025-06-063$30.48 $917,141SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise deriv2025-05-142025-05-165,144— $00SEC↗
XENE Xenon Pharmaceuticals Inc. M Exercise2025-05-142025-05-165,144$12.57 $64.7K7,144SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2024-06-052024-06-0515,542— $015,542SEC↗
FUSN Fusion Pharmaceuticals Inc D To issuer deriv2024-06-042024-06-04141,011— $00SEC↗
FUSN Fusion Pharmaceuticals Inc D To issuer deriv2024-06-042024-06-0430,000— $00SEC↗
FUSN Fusion Pharmaceuticals Inc D To issuer deriv2024-06-042024-06-0417,000— $00SEC↗
FUSN Fusion Pharmaceuticals Inc D To issuer deriv2024-06-042024-06-0417,000— $00SEC↗
FUSN Fusion Pharmaceuticals Inc D To issuer deriv2024-06-042024-06-0417,000— $00SEC↗
FUSN Fusion Pharmaceuticals Inc D To issuer2024-06-042024-06-0456,400— $00SEC↗
XENE Xenon Pharmaceuticals Inc. S Sale2024-03-072024-03-081,000$46.45 $46.5K14,000SEC↗
XENE Xenon Pharmaceuticals Inc. S Sale2024-03-072024-03-082,000$46.20 $92.4K2,000SEC↗
XENE Xenon Pharmaceuticals Inc. S Sale2024-03-072024-03-085,000$46.25 $231.3K9,000SEC↗
XENE Xenon Pharmaceuticals Inc. S Sale2024-03-072024-03-085,000$46.30 $231.5K4,000SEC↗
FUSN Fusion Pharmaceuticals Inc A Award deriv2023-06-142023-06-1417,000— $017,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2023-06-022023-06-0218,475— $018,475SEC↗
FUSN Fusion Pharmaceuticals Inc P Buy2022-08-112022-08-1144,400$2.03 $90.1K56,400SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2022-06-282022-06-2918,000— $018,000SEC↗
FUSN Fusion Pharmaceuticals Inc A Award deriv2022-06-142022-06-2217,000— $017,000SEC↗
FUSN Fusion Pharmaceuticals Inc P Buy2021-08-232021-08-232,829$7.99 $22.6K12,000SEC↗
FUSN Fusion Pharmaceuticals Inc P Buy2021-08-192021-08-203,000$8.05 $24.2K9,171SEC↗
FUSN Fusion Pharmaceuticals Inc P Buy2021-08-182021-08-20171$8.05 $1.4K6,171SEC↗
FUSN Fusion Pharmaceuticals Inc P Buy2021-08-162021-08-176,000$8.10 $48.6K6,000SEC↗
FUSN Fusion Pharmaceuticals Inc A Award deriv2021-06-042021-06-0717,000— $017,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2021-06-032021-06-0310,000— $010,000SEC↗
FUSN Fusion Pharmaceuticals Inc A Award deriv2020-06-252020-06-3030,000— $030,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2020-06-012020-06-0210,000— $010,000SEC↗
FUSN Fusion Pharmaceuticals Inc A Award deriv2020-01-192020-06-30141,011— $0141,011SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2019-09-162019-09-1815,000— $015,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2018-06-042018-06-0515,000— $015,000SEC↗
XENE Xenon Pharmaceuticals Inc. P Buy2017-08-112017-08-1415,000$2.82 $42.3K15,000SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2017-06-012017-06-023,500— $03,500SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2016-06-022016-06-033,500— $03,500SEC↗
XENE Xenon Pharmaceuticals Inc. A Award deriv2015-05-212015-05-225,144— $05,144SEC↗